The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET gene fusions and encouraging clinical trial outcomes. With the approval of ...
Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Spinal Fusion Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036" report has been added to ...
The NSCLC market size has undergone a revolutionary transformation over the last decade, driven by an increase in incident cases, the continuous adoption of approved therapies primarily immune ...
The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET gene fusions and encouraging clinical trial outcomes. With the approval of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results